The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia

Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Richard Albert, Adamanthia Liapikou, Albert Gabarrus, Ernesto Rangel, Josep Mensa, Antoni Torres

Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Richard Albert, Adamanthia Liapikou, Albert Gabarrus, Ernesto Rangel, Josep Mensa, Antoni Torres. The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia. Eur Respir J 2015; 46: Suppl. 59, 1843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia due to streptococcus pneumoniae in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015



Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Penicillin-resistant streptococcus pneumoniae is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008



Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013


Severe Chlamydia pneumoniae community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003

Dynamic of resistance of streptococcus pneumoniae strains from patients with CAP in theritary tertyary hospital: 10 years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001

Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002



Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013